Actively Recruiting
POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
Led by University of Florida · Updated on 2026-04-13
30
Participants Needed
1
Research Sites
366 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study to determine if using the (18)F-rhPSMA-7.3 PET-CT scan can improve the ability to spot serious prostate cancer in patients who have uncertain MRI results. These uncertain results include MRI results that showed a PIRADS 2 or PIRADS 3 area on the prostate. The investigators want to find out if this new test is better to detect prostate cancer than just doing a biopsy based on MRI alone.
CONDITIONS
Official Title
POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The patient is willing to provide signed informed consent and can comply with study procedures safely and feasibly
- The patient is male and at least 18 years old
- The patient has not previously had a prostate biopsy
- The patient had a pelvic mpMRI within the last 90 days to check for possible prostate cancer
- The patient is scheduled for a targeted MRI/ultrasound biopsy before recruitment
- The patient has PIRADS 2 and/or PIRADS 3 lesions identified by a board-certified radiologist
You will not qualify if you...
- Prior diagnosis of prostate cancer
- Any medical condition or situation that could affect study data or prevent study participation
- Participation in another interventional clinical trial within the past 30 days
- Known allergy to flotufolastat F 18 or any of its ingredients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UF Health - Jacksonville
Jacksonville, Florida, United States, 32209
Actively Recruiting
Research Team
S
Shelby Sparks
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here